Stefano Colloca

7.0k citations
54 papers · 2.0k · h-index 26

Impact in

Papers in

Co-authors
Riccardo Cortese (22 shared papers)Alfredo Nicosia (26 shared papers)Antonella Folgori (19 shared papers)Stefania Capone (17 shared papers)Adrian V. S. Hill (9 shared papers)Loredana Siani (9 shared papers)Sarah C. Gilbert (7 shared papers)Alessandra Vitelli (8 shared papers)
Journals
Vaccine (6 papers)Journal of Virology (5 papers)PLoS ONE (4 papers)Molecular Therapy (3 papers)Journal of Hepatology (3 papers)
Partner nations
ItalyUnited KingdomUnited States

In The Last Decade

Stefano Colloca

51 papers receiving 1.9k citations

Peers

Stefano Colloca
Comparison fields: 5 of 76
  • Virology 300
  • Hepatology 387
  • Immunology 514
  • Infectious Diseases 434
  • Epidemiology 785
Replace Antonella Folgori with:
Antonella Folgori Italy
Brenda L. Fredericksen United States
Thomas Krey Germany
Donna M. Tscherne United States
Denise M. McKinney United States
Eric M. Feeley United States
Yorihiro Nishimura Japan
John M. Polo United States
Sinu P. John United States
Krystyna Bieńkowska-Szewczyk Poland
Stefano Colloca relative to Antonella Folgori Italy Antonella Folgori's profile →
Citations per field
00.5×1.5×
Antonella Folgori · 1×
Citations per year

Countries citing papers authored by Stefano Colloca

Since Specialization
Citations

This map shows the geographic impact of Stefano Colloca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Colloca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Colloca more than expected).

Fields of papers citing papers by Stefano Colloca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefano Colloca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Colloca. The network helps show where Stefano Colloca may publish in the future.

Co-authors

The 25 scholars most cited alongside Stefano Colloca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stefano Colloca Line = papers co-authored together Stefano Colloca links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees
Nature Medicine ·Antonella Folgori, Stefania Capone, Lionello Ruggeri, Annalisa Meola, Elisabetta Sporeno, Bruno Bruni Ercole, Monica Pezzanera, Rosalba Tafi, Mirko Arcuri, Elena Fattori, Armin Lahm, Alessandra Luzzago, Alessandra Vitelli, Stefano Colloca, Riccardo Cortese, Alfredo Nicosia
2006239
2
Prime-boost vectored malaria vaccines: Progress and prospects
Human Vaccines ·Adrian V. S. Hill, Arturo Reyes‐Sandoval, Geraldine O’Hara, Katie Ewer, Alison M. Lawrie, Anna L. Goodman, Alfredo Nicosia, Antonella Folgori, Stefano Colloca, Riccardo Cortese, Sarah C. Gilbert, Simon J. Draper
2010151
3
Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8 + T-Cell Responses
Infection and Immunity ·Arturo Reyes‐Sandoval, Tamara Berthoud, Nicola Alder, Loredana Siani, Sarah C. Gilbert, Alfredo Nicosia, Stefano Colloca, Riccardo Cortese, Adrian V. S. Hill
2009146
4
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector
Proceedings of the National Academy of Sciences ·Alessandra Recchia, Robin J. Parks, Stefania Lamartina, Carlo Toniatti, Luisa Pieroni, Fabio Palombo, Gennaro Ciliberto, Frank L. Graham, Riccardo Cortese, Nicola La Monica, Stefano Colloca
1999130
5
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH
PLoS neglected tropical diseases ·Mohamed Osman, Anoop Mistry, Ada Keding, Rhian Gabe, Liz Cook, Sarah Forrester, Rebecca Wiggins, Stefania Di Marco, Stefano Colloca, Loredana Siani, Riccardo Cortese, Deborah F. Smith, Toni Aebischer, Paul M. Kaye, Charles Lacey
201797
6
Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults
Science Translational Medicine ·Christopher Green, Elisa Scarselli, Charles Sande, Amber Thompson, Catherine M. de Lara, Kathryn Taylor, Kathryn Haworth, Mariarosaria Del Sorbo, Brian Angus, Loredana Siani, Stefania Di Marco, Cinzia Traboni, Antonella Folgori, Stefano Colloca, Stefania Capone, Alessandra Vitelli, Riccardo Cortese, Paul Klenerman, Alfredo Nicosia, Andrew J. Pollard
201591
7
Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade
Nature Communications ·Anna Morena D’Alise, Guido Leoni, Gabriella Cotugno, Fulvia Troise, Francesca Langone, Imma Fichera, Maria De Lucia, Lidia Avalle, Rosa Vitale, Adriano Leuzzi, Veronica Bignone, Elena Di Matteo, Fabio Giovanni Tucci, Valeria Poli, Armin Lahm, Maria Teresa Catanese, Antonella Folgori, Stefano Colloca, Alfredo Nicosia, Elisa Scarselli
201976
8
A Novel Adenovirus Type 6 (Ad6)-Based Hepatitis C Virus Vector That Overcomes Preexisting Anti-Ad5 Immunity and Induces Potent and Broad Cellular Immune Responses in Rhesus Macaques
Journal of Virology ·Stefania Capone, Annalisa Meola, Bruno Bruni Ercole, Alessandra Vitelli, Monica Pezzanera, Lionello Ruggeri, M E Davies, Rosalba Tafi, Claudia Santini, Alessandra Luzzago, Tong‐Ming Fu, Andrew Bett, Stefano Colloca, Riccardo Cortese, Alfredo Nicosia, Antonella Folgori
200670
9
Construction of an rtTA2s-m2/ttskid-Based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and Non-Human primates
Molecular Therapy ·Stefania Lamartina, Luisa Silvi, Giuseppe Roscilli, Danilo R. Casimiro, Adam Simon, Mary-Ellen Davies, John W. Shiver, C. Daniela Rinaudo, Immacolata Zampaglione, Elena Fattori, Stefano Colloca, Odalys Gonzalez Paz, Ralph Laufer, Hermann Bujard, Riccardo Cortese, Gennaro Ciliberto, Carlo Toniatti
200363
10
Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials
Expert Review of Vaccines ·Stefania Capone, Anna Morena D’Alise, Virginia Ammendola, Stefano Colloca, Riccardo Cortese, Alfredo Nicosia, Antonella Folgori
201363
11
Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime–boost immunisation in non-human primates
Vaccine ·Stefania Capone, Arturo Reyes‐Sandoval, Mariarosaria Naddeo, Loredana Siani, Virginia Ammendola, Christine S. Rollier, Alfredo Nicosia, Stefano Colloca, Riccardo Cortese, Antonella Folgori, Adrian V. S. Hill
201060
12
Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections
Science Translational Medicine ·Geraldine Taylor, Michelle Thom, Stefania Capone, Angiolo Pierantoni, Efrain Guzman, Rebecca Herbert, Elisa Scarselli, Federico Napolitano, Alessandro Giuliani, Antonella Folgori, Stefano Colloca, Riccardo Cortese, Alfredo Nicosia, Alessandra Vitelli
201554
13
CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient
Molecular Therapy ·Daniela Benati, Francesca Miselli, Fabienne Cocchiarella, Clarissa Patrizi, Marta Carretero, S Baldassarri, Virginia Ammendola, Cristina Has, Stefano Colloca, Marcela Del Río, Fernando Larcher, Alessandra Recchia
201848
14
Combined Adenovirus Vector and Hepatitis C Virus Envelope Protein Prime-Boost Regimen Elicits T Cell and Neutralizing Antibody Immune Responses
Journal of Virology ·Alicja Chmielewska, Mariarosaria Naddeo, Stefania Capone, Virginia Ammendola, Ke Hu, Luke W. Meredith, Lieven Verhoye, Malgorzata Rychłowska, Rino Rappuoli, Jeffrey B. Ulmer, Stefano Colloca, Alfredo Nicosia, Riccardo Cortese, Geert Leroux‐Roels, Peter Balfe, Krystyna Bieńkowska-Szewczyk, Philip Meuleman, Jane A. McKeating, Antonella Folgori
201445
15
Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus
PLoS ONE ·Alessandra Vitelli, Mary R. Quirion, Chia-Yun Lo, Julia A. Misplon, Agnieszka Grabowska, Angiolo Pierantoni, Virginia Ammendola, Graeme E. Price, Mark R. Soboleski, Riccardo Cortese, Stefano Colloca, Alfredo Nicosia, Suzanne L. Epstein
201340
16
New Candidate Vaccines against Blood-StagePlasmodium falciparumMalaria: Prime-Boost Immunization Regimens Incorporating Human and Simian Adenoviral Vectors and Poxviral Vectors Expressing an Optimized Antigen Based on Merozoite Surface Protein 1
Infection and Immunity ·Anna L. Goodman, Christian Epp, David K. Moss, Anthony A. Holder, James M. Wilson, Guangping Gao, Carole A. Long, Edmond J. Remarque, A. W. Thomas, Virginia Ammendola, Stefano Colloca, Matthew D. J. Dicks, Sumi Biswas, D. Seibel, Leonie M. van Duivenvoorde, Sarah C. Gilbert, Adrian V. S. Hill, Simon J. Draper
201040
17
Transgene Optimization, Immunogenicity and In Vitro Efficacy of Viral Vectored Vaccines Expressing Two Alleles of Plasmodium falciparum AMA1
PLoS ONE ·Sumi Biswas, Matthew D. J. Dicks, Carole A. Long, Edmond J. Remarque, Loredana Siani, Stefano Colloca, Matthew G. Cottingham, Anthony A. Holder, Sarah C. Gilbert, Adrian V. S. Hill, Simon J. Draper
201138
18
A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines
Vaccine ·Daniela Peruzzi, Sridhar Dharmapuri, Agostino Cirillo, B Bruni, Alfredo Nicosia, Riccardo Cortese, Stefano Colloca, Gennaro Ciliberto, Nicola La Monica, Luigi Aurisicchio
200936
19
Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming–boosting with novel adenoviral vectors based on different serotypes
Gene Therapy ·Elena Fattori, Immacolata Zampaglione, Mirko Arcuri, Annalisa Meola, Bruno Bruni Ercole, A. Cirillo, Antonella Folgori, Andrew Bett, Manuela Cappelletti, Elisabetta Sporeno, R. Cortese, Alfredo Nicosia, Stefano Colloca
200636
20
Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors
Biotechnology and Bioengineering ·Matthew G. Cottingham, Fionnadh Carroll, Susan Morris, Alison Turner, Aisling Vaughan, Melissa C. Kapulu, Stefano Colloca, Loredana Siani, Sarah C. Gilbert, Adrian V. S. Hill
201135

About Stefano Colloca

Stefano Colloca is a scholar working on Epidemiology, Molecular Biology, Genetics, Immunology and Virology, having authored 54 papers that have together received 2.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (19 papers), HIV Research and Treatment (16 papers), Immunotherapy and Immune Responses (13 papers), Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (11 papers), vaccines and immunoinformatics approaches (9 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Virology (300 citations), Hepatology (387 citations), Immunology (514 citations), Infectious Diseases (434 citations) and Epidemiology (785 citations). Stefano Colloca has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Riccardo Cortese, Alfredo Nicosia, Antonella Folgori, Stefania Capone, Adrian V. S. Hill, Loredana Siani, Sarah C. Gilbert, Alessandra Vitelli, Arturo Reyes‐Sandoval and Virginia Ammendola. Their work appears in journals such as Vaccine, Journal of Virology, PLoS ONE, Molecular Therapy and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonella FolgoriBreakdown of academic impact, for papers by Brenda L. FredericksenBreakdown of academic impact, for papers by Thomas KreyBreakdown of academic impact, for papers by Donna M. TscherneBreakdown of academic impact, for papers by Denise M. McKinneyBreakdown of academic impact, for papers by Eric M. FeeleyBreakdown of academic impact, for papers by Yorihiro NishimuraBreakdown of academic impact, for papers by John M. PoloBreakdown of academic impact, for papers by Sinu P. JohnBreakdown of academic impact, for papers by Krystyna Bieńkowska-Szewczyk